Insights about U.S. Stocks that landed in the Red-Zone during Tuesday’s trade, are depicted underneath:
Cumulus Media Inc (NASDAQ:CMLS)’s shares dwindled -17.46%, during the last trading session.
Cumulus Media Inc. (CMLS), declared operating results for the three months and year ended December 31, 2014.
Capital expenditures for the three months ended December 31, 2014 totaled $5.6 million, comprised of ongoing maintenance and upgrades across our broadcast platform. Capital expenditures during the three months ended December 31, 2013 were $2.6 million.
On an actual basis, net proceed for the year ended December 31, 2014 raised $237.3 million, or 23.1%, to $1,263.4 million, contrast to $1,026.1 million for the year ended December 31, 2013. The raise resulted from raises of $178.7 million, $30.3 million, $16.2 million and $12.1 million in broadcast advertising, digital advertising, political advertising and license fees and other proceed, respectively. The broadcast advertising raise was primarily attributable to the addition of the operations of WestwoodOne, which was attained on December 12, 2013, and several new stations being operated under LMAs in Chicago and San Jose, CA. The raises were partially offset by decreases in local spot and national spot proceed. The raise in digital advertising was primarily due to raised Rdio user generation activity and digital commerce generated by our Sweetjack platform. The raise in political advertising proceed was due to additional activity associated with mid-term and gubernatorial elections in 2014, the even numbered year for elections.
On a pro forma basis, net proceed for the year ended December 31, 2014 raised $17.7 million, or 1.4%, to $1,263.4 million, contrast to $1,245.7 million for the year ended December 31, 2013. The raise resulted from a decrease of $39.2 million in advertising and raises of $28.0 million, $16.0 million and $12.9 million in digital advertising, political advertising and license fees and other proceed, respectively. Net broadcast advertising proceed was down due to an ongoing weakness in several large local markets. The raise in digital advertising proceed was primarily due to raised Rdio user generation activity. Political advertising raised due to additional activity associated with mid-term and gubernatorial elections in 2014, the even numbered year for elections.
Cumulus Media Inc. owns and operates commercial radio station clusters in the United States. It sells local, regional, and national advertising for broadcast on its radio stations. As of February 27, 2014, the corporation’s audio content was distributed through about 460 owned operated stations in 89 United States media markets; about 10,000 broadcast radio associates; and through various digital channels, counting a national streaming/mobile platform and partnership with digital audio provider. Cumulus Media Inc. was founded in 1997 and is headquartered in Atlanta, Georgia.
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), declined -15.98%, and closed at $1.42.
Cyclacel Pharmaceuticals, Inc. (CYCC), a biopharmaceutical corporation developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, declared that it intends to offer shares of ordinary stock in a public offering. H.C. Wainwright & Co., LLC will serve as the sole book runner for the offering. While the offering is predictable to price before 9:30 am EST on March 4, 2015, the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be accomplished, or as to the actual size or terms of the offering.
The offering will be made in the United States only by means of a prospectus supplement and an accorporationing prospectus filed as part of an effective “shelf” registration statement filed with the Securities and Exchange Commission on Form S-3 (File No. 333-187801), which was declared effective by the United States Securities and Exchange Commission, or the SEC, on April 22, 2013. Copies of the prospectus supplement and accorporationing prospectus, when accessible, can be obtained by request at H.C. Wainwright & Co., LLC by contacting by telephone at (212) 356-0530 or by e-mail at [email protected].
Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical corporation, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. The corporation’s oncology development programs comprise sapacitabine, an orally-accessible nucleoside analogue that interferes with DNA synthesis and repair by causing single-strand DNA breaks that could induce arrest of the cell division cycle at the G2/M checkpoint; and seliciclib, an orally-accessible 2nd generation CDK inhibitor that selectively inhibits a spectrum of enzyme targets comprising CDK2/E, CDK2/A, CDK7, and CDK9 that are central to the process of cell division and cell cycle control.
Axion Power International, Inc (NASDAQ:AXPW), dipped -5.93%, and closed at $ 0.241, hitting new 52-week low of $0.22. With recent incline, the year-to-date (YTD) performance reflected a -74.35% decline below last year. During the past month the stock loses -64.01%, bringing three-month performance to -81.87% and six-month performance to 152.99%.
Axion Power International, Inc. is engaged in the design, development, manufacture, and sale of advanced energy storage devices, components, and systems based on its patented PbC Technology. Its PbC batteries and components are used in energy system storage functions. The corporation also manufactures standard and specialty lead-acid batteries. Axion Power International, Inc. was founded in 2003 and is based in New Castle, Pennsylvania.
GrafTech International Ltd (NYSE:GTI), dropped -12.74%, and closed at $4.11.
GrafTech International Ltd. (GTI), declared financial results for the fourth quarter and full year ended December 31, 2014.
2014 Fourth Quarter Review:
- Net sales were $260 million, a decrease of 16 percent, contrast to $309 million in the same period of the preceding year.
- Stated net loss was $(83) million, or $(0.61) per diluted share, contrast to stated net loss of $(28) million, or $(0.21) per diluted share in the same period of the preceding year. These comprised of special charges1 (after tax) of $91 million in the fourth quarter of 2014 and special charges (after tax) of $24 million in the fourth quarter of 2013.
- Adjusted net revenue*, which excludes special charges, was $8 million, or $0.06 per diluted share, in the fourth quarter of 2014, as contrast to adjusted net loss* of $(4) million, or $(0.03) per diluted share, in the fourth quarter of 2013.
- EBITDA*, which excludes special charges, was $37 million, an raise of 13 percent, as contrast to $33 million in the same period of the preceding year.
- Operating cash flow was $38 million in the fourth quarter of 2014 and accessible liquidity at year-end was more than $300 million.
GrafTech International Ltd. manufactures and sells graphite and carbon material science-based solutions. It operates in two segments, Industrial Materials and Engineered Solutions. The Industrial Materials segment manufactures and delivers graphite electrodes, which are used to produce steel and other non-ferrous metals; carbon, semi-graphitic, and graphite refractory hearth linings for blast and submerged arc furnaces that are used to produce iron and ferro alloys; and petroleum needle coke, a crystalline form of carbon used in the production of graphite electrodes.
